Orchid Pharma

Orchid Pharma shares drop nearly 5% as Q4 net profit falls 32.4% YoY to Rs 22.3 crore

Orchid Pharma shares surge 4.4% after successful USFDA inspection at Alathur API facility

Orchid Pharma successfully completes USFDA inspection at Alathur API facility, secures EU GMP certification renewal

Orchid Pharma shares drop over 14% as net profit falls 25.63% YoY to ₹22.45 crore in Q3

Orchid Pharma shares jump nearly 4% following strong Q2 FY25 results

Orchid Pharma Q2 FY25 Results: Revenue jumps 12% to ₹222.7 crore, PAT up 26% YoY

Orchid Pharma shares drop over 8% after weak Q4 results

Stocks to watch: Adani Green Energy, Vedanta, Yes Bank, Hero MotoCorp, Eicher Motors and more

As Nifty Futures traded 50 points, or 0.26%, lower at 18925 on the Singapore Exchange, the SGX Nifty indicated that the domestic share market would have a negative opening.